INTRODUCTION
Delezene and Pozerski in 1903 reported that serum becomes proteolytic when shaken with chloroform. This observation has been repeatedly confirmed by subsequent investigators. It has also been shown that a variety of other agents and procedures will release the proteolytic activity of serum (Opie and Barker, 1907, 1908; Yamakawa, 1918; Pope, 1938; Juhling and W~hlish, 1938) . It has been postulated by some investigators (Delezene and Pozerski, 1903; Yamakawa, 1918; Sehmitz, 1937 , Iyengar, 1942 that the proteolytic activity is held in check by a protease inhibitor also present in serum, and that activation or liberation of the protease occurs when the inhibitor is removed.
The recent demonstration (Christensen, 1945; Christensen and MacLeod, 1945 ) that the protease of serum is present as a zymogen (plasminogen) which is catalytically converted to the active enzyme (plasmin) by the action of a bacterial klnase (streptokinase) led to a study of the mechanism of activation by chloroform, since it had also been shown that the chloroform-activated protease and plasmin are apparently identical (Christensen and MacLeod, 1945) . At least two mechanisms can be suggested to explain chloroform activation. Chloroform may exert a direct catalytic influence on the plasminogen,
• " converting it to plasmin, or chloroform may react with some other component of serum and exert its effect in an indirect manner, either by removing inhibitor and allowing spontaneous activation of the protease~ or by altering some substance in serum which in turn reacts with the plasminogen.
In order to determine which, if either, of the above postulates is correct, samples of serum were activated by treatment with chloroform and the development of spontaneous activity, the level of total activity, and the level of inhibitor were measured.
Methods and Martials
1. Total Proteolytic Acti~ity of Serum.--The method is based on the earlier observation that the plasminogen of serum or its globulin fraction is quantitatively convetted to plasmin almost instantaneously in the presence of an excess of streptokinase (Christensen, 1945; Christensen and MacLeod, 1945) . The plasminogen is quantitatively precipitated from serum by the addition of 2 volumes of 0.5 saturated ammonium sulfate. To determine plasminogen, 2.5 ml. of serum are mixed with 5.0 ml. of 0.5 saturated ammonium sulfate and the precipitate collected by centrifugation in a conical graduated tube. The supernatant is decanted and the precipitate made up to 1.0 ml. with saline buffer. This concentration procedure serves two purposes. The inhibitor is found largely in the albumin fraction of serum (Landsteiner, 1900; Grob, 1943) , thus the separation and discarding of this fraction minimizes the effect of serum inhibitor on the determination. Secondly, the two and a half-fold concentration of the proteolytic activity results in more accurate determinations with the test system used. For activation of the plasminogen, 1.0 ml. of the serum fraction solution is mixed with 0.1 ml. of a 1:10 dilution of a streptokinase concentrate and incubated for about 1 minute at 35°C. The plasmin mixture is then added to 6.0 ml. of 5 per cent gelatin solution, poured into a viscosimeter, and the rate of decrease in specific viscosity at 35°C. determined as outlined in a previous report (Christensen and MacLeod, 1945) . Both the enzyme and substrate solutions, as well as the viscosimeter are warmed to 35°C. before using. By definition, 1 plasmin unit is that amount of phismin which will cause a fall of 1 per cent per minute in the specific viscosity of the standard enzyme-substrate mixture. Prdiminary experiments with the lot of streptokinase employed had established the concentration to be used in order to produce maximum activation of the protease.
Spontaneous Proteolylic Activity of Serum.--Spontaneous activity determinations
were made in the same manner as the determinations of total activity with the exception that buffer was substituted for streptokinase solution.
Serum Teypsin
Inhib~or.--The available evidence (Schmitz, 1938; Grob, 1943; Christensen and MacLeod, 1945) indicates that there is present in serum a protease inhibitor identical with, or very. similar to, the crystalline inhibitor isolated by Kunitz and Northrop (1936) from the pancreas. The method of inhibitor titration adopted, therefore, is a modification of one recently devised by Kunitz t (1945) for the titration of pancreatic and soy bean inhibitors. ~The inhibitory power of the serum sample is expressed in terms of the amount of a standard preparation of crystalline pancreatic trypsin inhibitor necessary to produce the same degree of inhibition of a standard preparation of crystalline trypsin.
The determination is carried out as follows: 0.5 ml. of a solution of crystalline trypsin, containing 0.1 rag., is mixed with 0.5 ral. of appropriate dilutions of the inhibitor solution at pH 7.6. The mixture is incubated at 35°C. for 15 minutes to allow combination of the inhibitor and enzyme. At the end of this time, 1.0 ml. of the warmed substrate, 5 per cent casein in 10 per cent urea, is added and mixed. The mixtures are incubated for exactly 5 minutes, when the reaction is stopped by the addition of 3.0 ml. of 5 per cent trichloracetic acid. The tubes are shaken and allowed to stand for 10 to 15 minutes, then filtered to remove the precipitated protein. The extent of proteolysis is measured by determining the amount of acid-soluble chromogenic material in the filtrates by the copper-phenol method of Herriott (1941) as modified by Heidelberger and MacPherson (1943) . For convenience, the results are expressed in terms of the amount of crystalline tyrosine necessary to produce the same amount of color under the same conditions, although the color in the filtrates is due to other 1 We are very grateful to Dr. M. Kunitz for suggestions and advice regarding methods of inhibitor titration in advance of publication of his method, and for generous gifts of crystalline inhibitors for standardization.
substances in addition to the tryosine. Under these conditions, the amount of chromogenic material is a linear function of the concentration of free trypsin ( Fig. 1) , indicating that the amount of protcolysis is directly proportional to the free enzyme concentration. A calibration curve was prepared by adding varying amounts of the standard crystalline pancreatic trypsin inhibitor in a volume of 0.5 ml. to constant amounts of crystalline trypsin in 0.5 ml., incubating at pH 7.6, and reacting with substrate as described above. When the color values obtained in such an experiment are plotted, it is seen that the values fall along a sigmoid curve (Fig. 2) . Since it has been shown (Hussey and Northrop, 1922-23; Grob, 1943 ) that trypsin and inhibitor form a stoichiometric, reversible combination in accordance with the law of mass action, it is to be expected that the amounts of free or dissociated trypsin will fall along the familiar buffer type curve. Because the inhibition curve is sigmoid, the comparison point of the inhibitor titration is taken as that amount of inhibitor producing 50 per cent inhibition of the trypsin solution, since in this region the slopes of the curves to be compared are maximal and consequently the results will be least affected by experimental errors. The method is applicable over a fairly wide range of trypsin levels, since, as may be seen in Fig. 3 , there is a linear relationship between the amount of trypsin used and the amount of inhibitor necessary to produce 50 per cent inhibition. In the present study the amount of trypsin used liberates acid-soluble chromogenic material equivalent to 50 to 60 micrograms of tryosine under the conditions described.
In titrating the inhibitor levels of sera, it has been found that the majority of normal sera will give values within the workable range if 0.5, 0.4, 0.3, 0.2, and 0.1 ml. of a 1:50 ml. dilution, in pH 7.6 buffer made up to a volume of 0.5 ml., are added to the standard trypsin solution. The color values of the filtrates are plotted, and by interpolation, the quantity of serum necessary to produce 50 per cent inhibition is determined. By reference to the calibration curve the quantity of standard inhibitor necessary to produce 50 per cent inhibition of the trypsin solution can be found, and the inhibitory power of the serum can then be expressed in terms of milligrams of the standard per milliliter of serum. to insure rapid and complete solution of the casein. Apparently the addition of urea does not alter the course of either the inhibition or proteolysis, since comparable results were obtained when casein without urea was used. It has been found that the blank color values of urea-casein and casein solutions rise rather rapidly as the casein solutions stand, and it appears that some of this color arises at the expense of the chromogenic material liberated by trypsin action. For this reason solutions should be prepared immediatdy before use. Other samples of casein are satisfactory as substmtes, so long as they do not give blank values which are too high.
Casein-Urea

Standard Trypsin.--A sampIe of crystalline material purchased from the Plaut
Research Laboratories was used. The material contained about 85 per cent mag-nesium sulfate. A stock solution containing 2.0 mg./ml.was prepared in 0.05 N HCI. This Stock solUtion was stable for several weeks. This stock solution was diluted 1:10 with saline buffer pH 7.6 immediately before use. :As mentioned above, 0.5 ml. of this diluted solution, under the conditions of the test, liberates ehromogenic material equivalent to about 50 micrograms of tyrosine.
6. Standard Trypsin Inhibitor.--A sample of crystalline pancreatic inhibitor was kindly supplied by Dr. Kunitz.l It contained about 50 per cent magnesium sulfate. The total S was 0.089 mg. per rag. dry weight of the material. A stock solution containing 1 mg./ml, was made up in distilled water. This solution is also quite stable. Decreasing quantities, beginning with about 20 micrograms, in 0.5 ml. were made up in saline buffer pH 7.6 immediately before use in preparing the calibration curves.
7. The preparation of saline buffer, gelatin solutions for viscosity determinations, and other materials used has been described in previous reports (Christensen, 1945; Christensen and MacLeod, 1945) .
EXPERIMENTAL
It was felt that pertinent information regarding the mechanism of chloroform activation would be the rate and magnitude of the decrease in serum inhibitor and the rate and magnitude of the increase in spontaneous activity of the chloroform-treated serum. Accordingly, 100 ml. of fresh human serum were shaken with 10 ml. of chloroform for 2 minutes. At the end of this period an aliquot was removed and as much insoluble material and chloroform as possible sedimented from it by centrifugation in a Swedish angle centrifuge at about 5000 R.p.~r. This aliquot was titrated for inhibitor, spontaneous activity, and total activity by the methods outlined above. These determinations were repeated at intervals on successive aliquots of the chloroform-treated serum. Initial values for this serum were obtained on a portion not treated with chloroform. The results of this experiment ~re plotted in Fig. 4 .
It can be seen from Fig. 4 that immediately following treatoent with chloroform the inhibitor concentration of the serum dropped to less than 10 per cent of the original value. The total protease activity of the serum was also diminished immediately following chloroform treatment, probably due to denaturation of a portion of the enzyme, since it can be shown that continued shaking with chloroform eventually destroys most if not all protease activity. However, the most significant fact shown by this experiment is the long delay in the appearance of spontaneous activity in the treated serum. Further, the course of the activation of this protease is not that of a first order reaction, as is the activation of plasminogen by streptokinase. Rather, the curve suggests an autocatalytic type of reaction. On further analysis, it can be seen that the curve also deviates from that characteristic of an autocatalytic reaction in that there is less activity in the later stages of the reaction than expected. A possible explanation of this deviation may lie in the fact that in the presence of active plasmin, either plasmin, plasminogen, or both are quite unstable. It will be noted in Fig. 4 that the total protease activity of the treated serum begins to fall off at about the time spontaneous activity of the preparation becomes appreciable, suggesting digestion of one or both forms of the enzyme. Other experiments in this and other laboratories (EdsaU, 1946) have confirmed this loss of proteolytic activity in preparations which are partially or wholly activated. On the other hand, plasminogen preparations The total protease actiVity was determined by adding an excess of streptokinase to the treated serum. Spontaneously activated protease was determined without the; addition of streptokinase. Inhibitor is expressed as the amount of crystalline pan, creatic inhibitor necessary to produce the same amount of inhibition of the standard: trypsin solution as produced by the serum.
with little or no spontaneous activity do not show a loss of streptokinase 7 activatable activity when stored for weeks or months (Christensen, 1945; Christensen and MacLeod, 1945) .
This experiment has been repeated on several specimens of human and animal serum. The human sera tested all behaved in the same manner, that is, a rapid drop in the level of "inhibitor, followed by an acceleratingrate of spontaneous activation, together with a drop in total activity. Activation by chloroform in no instance resulted in liberation of more than half of the total proteolytic activity of the serum which was not treated with chloroform. In the case of the animal sera, a marked drop in inhibitor levels is seen, comparable to the drop in human sera, but no significant amount of proteolytic activity appears. Apparently the animal sera tested did not contain a protease analogous to plasminogen, since only very low levels of proteolytic activity were found either after chloroform treatment or treatment with streptokinase. The amount of proteolytic activity found was sufficient to cause lysis of fibrin clots, but not enough to produce significant hydrolysis of gelatin under the conditions employed.
DISCUSSION
The activation of plasminogen which occurs when serum is shaken with chloroform does not appear to be due to a direct action of chloroform on the enzyme. The observations supporting this view are as follows: First, it is likely that if chloroform acted directly on plasminogen to convert it to plasmin, activation would begin immediately or shortly after chloroform treatment. This is not the case, but rather there is a period of several days before demonstrable activation occurs. Second, one might expect that the activation curve would resemble that of a first order reaction, rather than that of an autocatalytic reaction.
It appears that the spontaneous activation of plasminogen is associated with the marked decrease in the concentration of serum inhibitor. Previous investigators have shown that crystalline trypsin inhibitor may be bound to serum proteins (Grob, 1943) , and Teale and Bach (1920) have shown that serum inhibitor is inactivated by chemical reagents only when coagulation of the serum proteins occurs. It is probable, therefore, that the denaturation of serum proteins occurring when serum is treated with chloroform is responsible for the rapid loss of inhibitor. It has also been shown (Christensen and MacLeod, 1945) that serum inhibitor, which is much less active against plasm~n than against trypsin, does produce inhibition of plasmin. These facts suggest that removal of serum inhibitor is essential for spontaneous activation of plasminogen, and that this removal is brought about by treatment with chloroform. In agreement with this hypothesis is the earlier observation (Chrlstensen and MacLeod, 1945 ) that serum fractions containing plasminogen will activate spontaneously in the refrigerator in the absence of chloroform when the inhibitor content of the fraction is low. H the inhibitor content of the fraction is high, spontaneous activation is delayed or prevented entirely.
It appears, therefore, that the spontaneous activation of plasminogen is analogous to the spontaneous activation of trypsinogen. Crude trypsinogen preparations which contain inhibitor do not activate spontaneously (Kuuitz and Northrop, 1935) . However, when the inhibitor is removed, the trypsinogen is rapidly and autocatalyticaUy converted to trypsin. The autoinactivation of plasmin and plasminogen in solutions containing free plasmin has prevented establishment of the exact nature of the spontaneous activation of plasminogen, and while the present experiments do not remove the possibility of the reaction of chloroform with a precursor, which in turn activates plasminogen, it does not appear unreasonable to suppose that the activation is autocatalytic. 2. Following a lag period of less than one to several days, proteolytic activity begins to appear in the chloroform-treated serum. Activity increases over a period of several days and then begins to diminish gradually. At about the time when the spontaneous activity begins to diminish, the total proteolytic activity of the preparation also begins to fall until finally the two curves coincide.
3. Chloroform treatment of serum appears to result in some destruction of plasminogen because not only is the total proteolytic activity of the chloroformtreated serum less than that of the serum before chloroform treatment, but the maximum spontaneous activity that develops is only about one-half the total proteolytic activity of serum before treatment with chloroform.
4. The spontaneous activation of plasminogen which occurs following removal of inhibitor appears to be autocatalytic in nature.
5. In the presence of active plasmin, both plasmin and plasminogen are destroyed.
